Who Supplies Metoclopramide? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Metoclopramide exports, with 321+ registered manufacturers shipping to buyers across 126+ countries — yet a handful of companies dominate the shipments. IPCA LABORATORIES LIMITED holds the largest share at 42.7% (export value: $9.7M). Close behind, AVET LIFESCIENCES PRIVATE LIMITED (7.5%, $1.7M). MAAN PHARMACEUTICALS LTD (4.0%, $906.8K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Metoclopramide? Top Manufacturers & Their Buyers
Flow of Metoclopramide from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Metoclopramide Supplier Network — Key Market Intelligence
The Metoclopramide export market from India is led by IPCA LABORATORIES LIMITED, which alone commands a 42.7% share, shipping $9.7M worth of product across 102 shipments. The second-largest exporter, AVET LIFESCIENCES PRIVATE LIMITED, contributes $1.7M (7.5%) to the overall market. Combined, the top two suppliers alone account for 50.2% of all Metoclopramide exports, indicating a relatively concentrated supply base.
Across all 321 tracked manufacturers, the total Metoclopramide export value stands at $22.7M from 2.1K shipments. The market average shipment value is $11.1K. The single largest buyer relationship in terms of trade value is AVET PHARMACEUTICALS INC, receiving $1.0M worth of product.
The combined buyer network spans 17 named purchasing companies, including APOTEX PTY LTD, ORION CORPORATION, Arrow Pharmaceutical, AVET PHARMACEUTICALS INC, YAR PYE COMPANY LIMITED and 12 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1IPCA LABORATORIES LIMITED
IPCA LABORATORIES LIMITED is the first-largest Metoclopramide exporter from India, with a market share of 42.7% and a total export value of $9.7M across 102 shipments. Their average shipment value of $95.0K is above the market average of $11.1K, suggesting premium or bulk contract pricing.
IPCA LABORATORIES LIMITED serves 5 named buyers in our database. NA is the dominant customer, accounting for 95.3% of this supplier's tracked business. Top customers include:
• NA — $9.2M across 97 shipments (95.3% of this supplier's total exports)
• TO THE ORDER — $225.2K across 2 shipments (2.3% of this supplier's total exports)
• APOTEX PTY LTD — $127.9K across 1 shipments (1.3% of this supplier's total exports)
• ORION CORPORATION — $57.7K across 1 shipments (0.6% of this supplier's total exports)
• Arrow Pharmaceutical — $48.5K across 1 shipments (0.5% of this supplier's total exports)
Key Insight: IPCA LABORATORIES LIMITED's per-shipment value of $95.0K is 759% above the market average of $11.1K, consistent with large-order contracts or value-added formulations.
2AVET LIFESCIENCES PRIVATE LIMITED
AVET LIFESCIENCES PRIVATE LIMITED is the second-largest Metoclopramide exporter from India, with a market share of 7.5% and a total export value of $1.7M across 30 shipments. Their average shipment value of $57.0K is above the market average of $11.1K, suggesting premium or bulk contract pricing.
AVET LIFESCIENCES PRIVATE LIMITED serves 2 named buyers in our database. AVET PHARMACEUTICALS INC is the dominant customer, accounting for 59.8% of this supplier's tracked business. Top customers include:
• AVET PHARMACEUTICALS INC — $1.0M across 18 shipments (59.8% of this supplier's total exports)
• AVET PHARMACEUTICALS INC — $688.4K across 12 shipments (40.2% of this supplier's total exports)
Key Insight: AVET LIFESCIENCES PRIVATE LIMITED's per-shipment value of $57.0K is 416% above the market average of $11.1K, consistent with large-order contracts or value-added formulations.
3MAAN PHARMACEUTICALS LTD
MAAN PHARMACEUTICALS LTD is the third-largest Metoclopramide exporter from India, with a market share of 4.0% and a total export value of $906.8K across 9 shipments. Their average shipment value of $100.8K is above the market average of $11.1K, suggesting premium or bulk contract pricing.
MAAN PHARMACEUTICALS LTD serves 3 named buyers in our database. YAR PYE COMPANY LIMITED is the dominant customer, accounting for 98.5% of this supplier's tracked business. Top customers include:
• YAR PYE COMPANY LIMITED — $892.8K across 9 shipments (98.5% of this supplier's total exports)
• AHMED BIN ALWAN FOR — $7.6K across 0 shipments (0.8% of this supplier's total exports)
• YAR PYE COMPANY LIMITED — $6.4K across 0 shipments (0.7% of this supplier's total exports)
Key Insight: MAAN PHARMACEUTICALS LTD's per-shipment value of $100.8K is 812% above the market average of $11.1K, consistent with large-order contracts or value-added formulations.
4LINCOLN PHARMACEUTICALS LTD
LINCOLN PHARMACEUTICALS LTD is the fourth-largest Metoclopramide exporter from India, with a market share of 3.8% and a total export value of $862.6K across 19 shipments. Their average shipment value of $45.4K is above the market average of $11.1K, suggesting premium or bulk contract pricing.
LINCOLN PHARMACEUTICALS LTD serves 5 named buyers in our database. HEKO PHARMACY LTD is the dominant customer, accounting for 92.2% of this supplier's tracked business. Top customers include:
• HEKO PHARMACY LTD — $795.3K across 18 shipments (92.2% of this supplier's total exports)
• MAKANS LIMITED — $49.3K across 1 shipments (5.7% of this supplier's total exports)
• RAMADA TRADING PLC — $10.0K across 0 shipments (1.2% of this supplier's total exports)
• YASH PHARMACEUTICALS — $4.4K across 0 shipments (0.5% of this supplier's total exports)
• KOKNAR TAS ITH IHR S — $3.6K across 0 shipments (0.4% of this supplier's total exports)
Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $45.4K is 311% above the market average of $11.1K, consistent with large-order contracts or value-added formulations.
5BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED
BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the fifth-largest Metoclopramide exporter from India, with a market share of 3.7% and a total export value of $840.4K across 35 shipments. Their average shipment value of $24.0K is above the market average of $11.1K, suggesting premium or bulk contract pricing.
BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BAXTER HEALTHCARE PTY LIMITED — $372.1K across 15 shipments (44.3% of this supplier's total exports)
• BAXTER CORPORATION CANADA — $224.3K across 9 shipments (26.7% of this supplier's total exports)
• BAXTER HEALTHCARE PTY LIMITED — $152.1K across 6 shipments (18.1% of this supplier's total exports)
• BAXTER HEALTHCARE L — $53.7K across 2 shipments (6.4% of this supplier's total exports)
• BAXTER DISTRIBUTION — $38.1K across 2 shipments (4.5% of this supplier's total exports)
Key Insight: BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED's per-shipment value of $24.0K is 117% above the market average of $11.1K, consistent with large-order contracts or value-added formulations.
6ADCOCK INGRAM LIMITED
ADCOCK INGRAM LIMITED is the fifth-largest Metoclopramide exporter from India, with a market share of 1.6% and a total export value of $351.9K across 105 shipments. Their average shipment value of $3.4K is below the market average of $11.1K, reflecting a high-volume, competitive pricing strategy.
ADCOCK INGRAM LIMITED serves 4 named buyers in our database. ADCOCK INGRAM LIMITED. is the dominant customer, accounting for 73.8% of this supplier's tracked business. Top customers include:
• ADCOCK INGRAM LIMITED. — $259.6K across 77 shipments (73.8% of this supplier's total exports)
• ADCOCK INGRAM LIMITED. — $52.9K across 16 shipments (15.0% of this supplier's total exports)
• OETHMAAN BIOSIMS PTY — $23.9K across 7 shipments (6.8% of this supplier's total exports)
• OETHMAAN BIOSIMS PTY — $15.5K across 5 shipments (4.4% of this supplier's total exports)
Key Insight: ADCOCK INGRAM LIMITED operates with high shipment frequency (105 shipments) at a per-shipment value of $3.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Metoclopramide Flows
Once Metoclopramide leaves the manufacturing plants of companies like IPCA LABORATORIES LIMITED and AVET LIFESCIENCES PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $22.7M. Finland absorbs the largest share at 28.5% ($6.5M), followed by United States (19.3%) and Australia (13.2%).
In Finland — the top destination — named importers include ORION CORPORATION. In United States, key buyers are AVET PHARMACEUTICALS INC., AVET PHARMACEUTICALS INC.
This geographic spread reflects Metoclopramide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Metoclopramide Go? Top Importing Countries & Their Buyers
Trade flow of Metoclopramide exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Finland
Finland ranks as the first-largest destination for Metoclopramide imports from India, with a total trade value of $6.5M across 7 shipments — representing a 28.5% share of all Metoclopramide exports. The average shipment value of $922.9K is above the global average of $11.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Metoclopramide importers in Finland: ORION CORPORATION is the largest buyer, accounting for 3.7% ($242.1K) of this market's total imports.
• ORION CORPORATION — $242.1K (3.7% of Finland's total)
Key Insight: Finland's per-shipment average of $922.9K (8252% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Finland is a key market for Metoclopramide imports from India.
2United States
United States ranks as the second-largest destination for Metoclopramide imports from India, with a total trade value of $4.4M across 32 shipments — representing a 19.3% share of all Metoclopramide exports. The average shipment value of $136.8K is above the global average of $11.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Metoclopramide importers in United States: AVET PHARMACEUTICALS INC. is the largest buyer, accounting for 42.2% ($1.8M) of this market's total imports.
• AVET PHARMACEUTICALS INC. — $1.8M (42.2% of United States's total)
• AVET PHARMACEUTICALS INC — $1.3M (29.6% of United States's total)
Key Insight: United States's per-shipment average of $136.8K (1138% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Metoclopramide imports from India.
3Australia
Australia ranks as the third-largest destination for Metoclopramide imports from India, with a total trade value of $3.0M across 21 shipments — representing a 13.2% share of all Metoclopramide exports. The average shipment value of $142.1K is above the global average of $11.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Metoclopramide importers in Australia: BAXTER HEALTHCARE PTY. LIMITED is the largest buyer, accounting for 12.5% ($372.1K) of this market's total imports.
• BAXTER HEALTHCARE PTY. LIMITED — $372.1K (12.5% of Australia's total)
• APOTEX PTY LTD — $200.1K (6.7% of Australia's total)
• BAXTER HEALTHCARE PTY LIMITED — $152.1K (5.1% of Australia's total)
Key Insight: Australia's per-shipment average of $142.1K (1186% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Metoclopramide imports from India.
4Canada
Canada ranks as the fourth-largest destination for Metoclopramide imports from India, with a total trade value of $1.6M across 10 shipments — representing a 7.0% share of all Metoclopramide exports. The average shipment value of $157.7K is above the global average of $11.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Metoclopramide importers in Canada: MARCAN PHARMACEUTICALS INC, is the largest buyer, accounting for 18.9% ($298.8K) of this market's total imports.
• MARCAN PHARMACEUTICALS INC, — $298.8K (18.9% of Canada's total)
• BAXTER CORPORATION CANADA — $224.3K (14.2% of Canada's total)
Key Insight: Canada's per-shipment average of $157.7K (1327% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Metoclopramide imports from India.
5Myanmar
Myanmar ranks as the fifth-largest destination for Metoclopramide imports from India, with a total trade value of $1.0M across 4 shipments — representing a 4.5% share of all Metoclopramide exports. The average shipment value of $254.1K is above the global average of $11.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Metoclopramide importers in Myanmar: YAR PYE COMPANY LIMITED is the largest buyer, accounting for 88.4% ($898.1K) of this market's total imports.
• YAR PYE COMPANY LIMITED — $898.1K (88.4% of Myanmar's total)
Key Insight: Myanmar's per-shipment average of $254.1K (2199% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Myanmar is a key market for Metoclopramide imports from India.
People Also Ask — Metoclopramide Supplier & Trade Network
Who are the top suppliers of Metoclopramide from India?+
Which companies buy Metoclopramide from Indian manufacturers?+
Where does Metoclopramide exported from India go?+
What is the market share of the top Metoclopramide supplier from India?+
What is the average shipment value for Metoclopramide exports from India?+
Is Metoclopramide manufactured in India and exported globally?+
Which country imports the most Metoclopramide from India?+
Who are the buyers of Metoclopramide in United States?+
How concentrated is the Metoclopramide supplier market in India?+
How do I find verified buyers for Metoclopramide in specific countries?+
Metoclopramide Trade Network — Key Takeaways
- 1IPCA LABORATORIES LIMITED is India's dominant Metoclopramide exporter with a 42.7% market share and $9.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 321 suppliers collectively account for 63.3% of all tracked Metoclopramide exports, with a combined trade value of $22.7M.
- 3Finland is the largest destination market, absorbing 28.5% of India's Metoclopramide exports ($6.5M). United States (19.3%) and Australia (13.2%) follow.
- 4With 2.1K total shipments averaging $11.1K each, the Metoclopramide export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include APOTEX PTY LTD, ORION CORPORATION, AVET PHARMACEUTICALS INC, AVET PHARMACEUTICALS INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 126 countries
Network value: $22.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Metoclopramide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Metoclopramide.
- 2.Flow Mapping: 321 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,053 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 126 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,053 Verified Shipments
321 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists